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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Human infections by a new avian influenza A (H7N9) virus have been re-
ported. As of April 23, 2013, there were 108 confirmed cases including 22 deaths in China.
Methods: Influenza protein sequences were downloaded from the Influenza Virus Resource and
GISAID EpiFlu databases. Pairwise nucleotide identities were computed for assessing the evolu-
tionary distance of H7N9 to other known avian and human viruses, and multiple sequence
alignments with their position-specific entropy values were used in discussing how mutations
on species-associated signature positions were introduced in the new H7N9 which may steer
its way to human infection.
Results: This report analyzed the genomic characteristics of this new H7N9 virus. Nucleotide
sequence analysis clearly reveals its origin from avian viruses. In this article, we particularly
focus on its internal genes that are found to derive from H9N2danother subtype of avian influ-
enza A virus which has been circulating in birds for years. Amino acid sequences at species-
specific genomic positions were examined. Although the new virus contains mostly avian-like
residues at these signature positions, it does contain several human-like signatures. For
instance, at the position 627 of PB2, the new virus has human-characteristic K instead ofenter for Emerging Viral Infections, College of Medicine, Chang Gung University, 259 Wenhua 1st
u.edu.tw (G.-W. Chen), srshih@mail.cgu.edu.tw (S.-R. Shih).
ight ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
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Human infections by a new avian influenza A (H7N9) 313avian-characteristic E; in addition, PB2-627K, PA-100A, PA-356R, and PA-409N are also human-
like signatures in the new H7N9 virus.
Conclusion: The new H7N9 is an avian influenza A virus; however, it does harbor several human
virus-like signatures, which raises great concern that it may have a higher probability to cross
species barriers and infect humans.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Influenza virus can infect various hosts, including avian and
mammals. While it is generally true that there exists a
species barrier to prevent avian influenza virus from
infecting humans, sporadic human infections by avian
influenza viruses have been continuously reported.1 In
particular, subtypes H5N1 and H7N7 of influenza A viruses
have caused mortalities in humans.2e4
Influenza A viruses are enveloped negative-stranded RNA
viruses with a segmented genome and are members of the
Orthomyxoviridae family. There are eight RNA segments
packaged in the viral core. Virus attacks cells through
binding of the viral hemagglutinin (HA) to sialic acid-
containing receptor. Upon leaving the infected cells, viral
neuraminidase (NA) cleaves sialic acid to release its binding
to HA. During its stay inside of the cells, virus utilizes its
ribonucleoprotein (RNP) complex and cellular factors to
replicate. Each RNP complex comprises an RNA strand
wrapped by 3 polymerase proteins (polymerase basic 2,
polymerase basic 1, and polymerase A, or PB2, PB1, and PA
in short) and nucleoprotein NP. The RNP complex executes
viral RNA transcription and replication in host nucleus,
which provides opportunities to hijack resources from host
cells.5 Host proteins are generally assumed to be involved
in the influenza A virus life cycle, and the lack of essential
cellular proteins or the presence of inhibitory factors will
influence the ability of virus to replicate. During the
replication process, influenza A virus must overcome the
host cellular microenvironment by affecting normal func-
tions of cellular proteins.
A new subtype of avian influenza virus H7N9 emerged in
China in March 2013, and growing number of fatal infections
have been recorded since then.6 This new virus emerged
from reassortment of at least three subtypes of avian influ-
enza virusesdits HA derived from H7N3, NA from H7N9 and
all other six internal genes from H9N2.6 In particular, the HA
protein has a Q226L mutation, which is associated with
increased binding to mammalian-like receptors bearing the
alpha-2,6-receptor in the human upper airway.7,8 Also found
is the S31N mutation in the M2 protein, suggesting its resis-
tance to the M2 channel blockers amantadine and rai-
mantadine.9,10 One key signature amino acid at 627 in its PB2
mutated to lysine, which is known to associate with
mammalian adaptation and respiratory-droplet transmission
of the highly pathogenic avian influenza virus H5N1.7,11
Large-scale scanning of influenza A viral genome se-
quences identified host-specific genomic signatures of
human and avian influenza viruses.12,13 These species-
associated positions help in revealing the evolutionary
preferenceof influenza viruseswhich is to attempt todestroy
the barriers between the two host species. The introductionof genetic variations to viral RNP genes is considered one of
themajor determinants to overcome the species barriers.5 In
particular, three genetic substitutions K627E, N701D, and
R591Q in the PB2 segment of influenza virus, have been re-
ported to affect host cell tropism.11,14,15 A single substitution
of E (Glu) to K (Lys) at the PB2-627 position in avian influenza
viruses significantly enhances polymerase activity,16 viral
replication,17 transmission ability, and pathogenicity in
mammalian cells and mice.11,18
This work analyzed and compared the genomes of H7N9
viruses isolated from fatal cases with those of other human
and avian influenza A viruses. We particularly focus on the
PB2 gene, due to the finding that the novel avian-origin
H7N9 virus contains a human-like signature at position 627
of PB2, which has raised the concern that the new H7N9
virus can better adapt to humans.
Materials and methods
Nucleotide sequences and analysis
Nucleotide sequences for avian influenza A virus PB2 gene
were downloaded from the Influenza Virus Resource (IVR) of
the National Center for Biotechnology Information (http://
www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html), including
all-time 943 avian H5N1, 160 human H5N1, 287 avian H9N2,
and five human H9N2 viruses. Human influenza A virus PB2
sequences were also obtained from IVR for comparative
analysis. They include only recent Taiwanese strainsd12
new H1N1 (JaneFeb, 2008), 17 old H1N1 (Mar 2007eDec
2008), and seven H3N2 viruses (Jan 2007eJan 2008). All IVR
sequences downloaded were full-length with redundancies
removed. New H7N9 nucleotide sequences for three recent
human cases were downloaded from the GISAID EpiFlu
database (http://platform.gisaid.org). Pairwise sequence
identity was computed by the global pairwise alignment
program needle of EMBOSS package.19 In particular, A/
Shanghai/1/2013 was used as a reference sequence to
compute the pairwise identities for the other PB2 sequences.
MATLAB R2009b (The MathWorks, Inc., Natick, MA, USA) was
used to produce the boxplots for these pairwise identities.
Protein sequences and analysis
Human and avian amino acid signatures for influenza A virus
internal genes are based on Chen et al.13 All full-length
protein sequences for each of the influenza A virus inter-
nal genes were downloaded from IVR, without collapsing
identical sequences. New H7N9 protein sequences for three
recent human cases in China were downloaded from the
GISAID EpiFlu database.
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Nucleotide sequence identities of the new H7N9
PB2 gene compared with other viruses
PB2 nucleotide sequence (2280-nt) of A/Shanghai1/2013 (1
of the 3 new H7N9 cases in China in April 2013) was used as
a reference sequence to compute the sequence identities
for other PB2 sequences. Fig. 1 shows the boxplots of these
identities for each of the selected virus groups. It is
observed that the three human virus groups all displayed
relatively small median values (82.0e83.9% for recent
Taiwanese new H1N1, seasonal H1N1, and seasonal H3N2).
Their identity ranges were also narrow, apparently due to
the limited virus populations we chose to sample. Never-
theless, Taiwanese new H1N1 viruses displayed slightly
larger sequence identities to the new H7N9 PB2 among
these three human viruses, reflecting the fact that PB2 of
the new H1N1 in 2009 originated from the avian virus of
North American lineage.20Figure 1 Boxplots for nucleotide sequence identities of influenz
2013(H7N9). Median identities from left to right are 87.1, 88.1, 86
from left to right are 99.2, 88.2, 95.7, 88.4, 84.1, 83.0 and 82.2, re
83.8, 85.4, 83.8, 82.5 and 81.9, respectively. Identities were com
produced by MATLAB 2009b. Av Z avian, Hu Z human; n Z numbWhile the range of identities also appeared narrow for
the five human-isolated H9N2 viruses (all five in Hong Kong
from 1997 to 1999), the median identity is 88.1%, which is
clearly higher than in those Taiwanese human PB2 se-
quences. The median identity for human-isolated H5N1 vi-
ruses (86.5%) is also larger than those human viruses, and
their range is bigger (85.4e88.4%) because of a much larger
sample size (n Z 160), time span (1997e2012) as well as
geographic variation than those of human H9N2 cases.
However, not only did avian H9N2 and avian H5N1 viruses
exhibit larger median identities (87.1% and 86.3%, respec-
tively), their ranges were also extensively stretched
(81.4e99.2% for avian H9N2, and 83.4e95.7% for avian
H5N1), apparently due to their large sampling sizes as well
as intrinsic genetic diversities in various bird populations.
It is mentioned that the PB2 sequence varies only slightly
among these three H7N9 cases (identities 99.6e99.9%). As a
result, alternatively using either the other two (A/
Shanghai/2/2013 or A/Anhui/1/2013) as a reference would
not affect the sequence identity statistics reported above,
nor produce any visible difference in Fig. 1.a A PB2 in various virus groups, with respect to A/Shanghai/1/
.3, 86.5, 83.9, 82.7 and 82.0, respectively. Maximum identities
spectively. Minimum identities from left to right are 81.4, 87.9,
puted by the program needle in EMBOSS package. Plots were
er of isolates.
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H7N9
Chen et al utilized an entropy-based method and summa-
rized 47 amino acid signatures for human and avian influ-
enza A viruses, respectively.19 Table 1 lists these positions,
together with the amino acid compositions of the new H7N9
as well as all-time avian H5N1, human H5N1, avian H9N2,
and human H9N2 viruses. Numbers included in the paren-
theses are the virus counts exhibiting one particular amino
acid type. Forty-two of these signatures are avian-like for
the new H7N9 viruses, reinforcing the earlier indications
that the new virus is avian-originated.6,21 It is noted that
four signatures have already gone human-like, including
PB2 627 from E to K, PA 100 from V to A, PA 356 from K to R,
and PA 409 from S to N. Also characteristic to this new virus
is a truncated NS1 of 217-aa, rather than the usually seen
230-aa in other viruses.
We also include both avian and human H9N2 signatures
in Table 1 for assessing their potential of possessing human-
like residues before the H9N2 viruses contributed their in-
ternal genes to the new H7N9 viruses.6,21 It appears that all
avian/human H9N2 viruses contain avian-like residues at
these 47 signature positions, except that PB2 567 of five
human cases all exhibited E, which is neither a human nor
avian characteristic. Carefully examining the amino acid
sequences for these avian H9N2 viruses, however, identified
a number of signature positions which could potentially
display a human-like residue. Consider PA-409, for
example, while 250 of 342 avian H9N2 viruses investigated
contain an avian-like residue S, there are 91 viruses (or
26.6%) displaying a human residue N. Nevertheless, this
human-like residue also appears in the newly emerged
H7N9 viruses. Another example is PA-356, which shows a
human-like residue R in the new H7N9 viruses. Twelve of
342 (3.5%) H9N2 avian viruses are found to have R at this
position in addition to the dominant avian-like K. More such
human-residue-appearing positions are noticed in these
avian H9N2 samples, although such appearances have not
been observed as yet in the new H7N9 viruses. They are
shown in boldface in Table 1, including PB2-44 and -702, PA-
57, NP-214 and -372, M1-115 and -121, and M2-20.
Many humans were infected by avian H5N1 viruses since
the first reported case in Hong Kong in 1997. This virus is
highly pathogenic to both their avian hosts as well as to
humans. Table 1 includes the amino acid statistics of avian
and human H5N1 viruses. Although the primary residues are
all avian-like for both of them, some human-like residues
are seen as a secondary residue in avian H5N1 and found to
stay in human H5N1 as we have observed in avian H9N2
viruses earlier. Examples include PB2-627, PA-404 and 409,
and M1-137. However, some human-like residues appear
only in avian and yet not (or less) in human cases. These
include PB2-702, PB1-327, PA-100, NP-33 and -372, and M2-
11 and -20.PB2 627K appeared more in human cases
Special emphasis was placed on the species-associated PB2-
627. Because H5N1 viruses have been circulating in wild
birds and poultry for nearly two decades and human caseshave continuously been reported, we analyzed 627 K/E for
H5N1 which was isolated from avian sources versus humans.
Table 2 summarizes the statistics of PB2 627 from 1047
avian H5N1, 177 human H5N1, 301 avian/human H9N2, and
seven new H7N9 viruses. It is seen that human H5N1 has the
highest K fraction of 27.68%, followed by avian H5N1 of
23.11%. This ratio is extremely small for all H9N2 PB2-627
(1.33%), suggesting their low pathogenicity to humans.
Thus for all three published H7N9 genomes which showed K
in PB2-627.Discussion
HA, on the surface of the virus particle, sits in the cockpit
which pilots the avian influenza A virus to other species,
such as humans. It has been reported that position 226 is
located at the receptor-binding site of HA protein, and a
change from Q to L at this position in an H5N1 virus would
increase its binding affinity to 2-6 linked sialic acid, which is
a sugar in the receptors of human respiratory epithelium.22
Although the first H7N9 isolate in ChinadA/Shanghai/1/
2013, still contained a 226Q, a number of subsequent iso-
lates (A/Shanghai/2/2013, A/Anhui/1/2013, A/Zhejiang/
DTID-ZJU01/2013) were found to have a Q226L substitu-
tion. This raised the concern that the new H7N9 would soon
be capable of transmission to humans. A 5-aa deletion in
the stalk region of NA protein was also noticed in this new
virus, which is similar to the 19-aa deletion of the NA stalk
in H5N1. Although it is still unclear how such genetic
alteration may be involved in human transmission, it is re-
ported that the length of stalk may be associated with viral
virulence.23
This study focuses on the internal genes of influenza A
viruses, which are important for viral replication and viru-
lence. It has been reported that the new H7N9 virus ac-
quired its internal genes from H9N2 virus. Our analysis
shows that, among those 47 signature positions that sepa-
rated human and avian viruses in these internal genes, PB2-
627, and PA-100, -356 and -409 have already become
human-like. In particular the drift of PB2-627 from E to K
has been considered a major mutation for an avian virus to
adapt to mammalian species. From Table 1, however, we
see very few cases of PB2-627K (4 of 296 avian H9N2 viruses)
and PA-100A (2 of 342 avian H9N2 viruses) in hundreds of
our collected H9N2 samples. However, human-like residues
are seen in PA-356 and 409 more frequently. For example,
human-like residue N is seen in PA-409 in 26.6% of the avian
H9N2 population. Since only limited number of H7N9 iso-
lates are available at present, it is speculated that the
positions carrying more human-like residues in H9N2 viruses
may possess the potential to emerge in the new H7N9 vi-
ruses, for example, PB2-44 to S, PB2-702 to R, NP-214 to K,
NP-372 to D, etc. Certainly we cannot rule out the possi-
bility for other human-like residues to appear in the new
H7N9 viruses. Two such examples would be PB2-627 from E
to K and PA-100 from V to A in H7N9, in both cases only very
limited human-like residues were observed in their ances-
tral H9N2 isolates.
Fig. 1 shows that avian H9N2 and avian H5N1 displayed an
overall higher PB2 sequence identity than the others. In
particular, 29 avian H9N2 viruses aremore than 95% identical
Table 1 Amino acid compositions at 47 species-associated signature positions for H5N1, H9N2, and H7N9 viruses.










PB2 44 A S A(1046), S(1) A(177) A(279), S(16), T(2) A(5) A(3)
199 A S A(1044), T(2), S(1) A(170), S(7) A(297) A(5) A(3)
271 T A T(1043), M(3), A(1) T(174), M(2), A(1) T(292), M(4), I(1) T(5) T(3)
475 L M L(1041), M(6) L(176), F(1) L(296), W(1) L(5) L(3)
567 D N D(1041), E(5), N(1) D(160), E(17) D(279), E(18) E(5) D(3)
588 A I A(924), T(112), V(10), I(1) A(172), T(5) A(239), T(26), V(25), I(7) A(5) A(3)
613 V T V(1039), A(8) V(175), A(2) V(293), A(2), I(2) V(5) V(3)
627 E K E(805), K(242) E(128), K(49) E(240), V(51), K(4), G(1) E(5) K(3)
702 K R K(1031), R(15), T(1) K(172), R(5) K(249), R(48) K(5) K(3)
PB1 327 R K R(1153), K(23), W(1) R(163), K(2) R(322) R(5) R(3)
336 V I V(1170), I(5), A(1) V(165) V(315), I(5), A(2) V(5) V(3)
PA 28 P L P(1231), L(2), T(2), S(1) P(179) P(342) P(5) P(3)
55 D N D(1235), N(1) D(179) D(340), N(2) D(5) D(3)
57 R Q R(1228), Q(7), W(1) R(179) R(325), Q(15), K(2) R(5) R(3)
100 V A V(1197), A(20), I(18), F(1) V(143), I(36) V(311), I(27), A(2), D(2) V(5) A(3)
225 S C S(1233), G(1), N(1), R(1) S(179) S(341), C(1) S(5) S(3)
268 L I L(1232), F(2), I(1), V(1) L(179) L(339), I(2), P(1) L(5) L(3)
356 K R K(1231), R(3), I(1) K(178), R(1) K(330), R(12) K(5) R(3)
404 A S A(939), S(288), T(5), P(3) A(134), S(44) A(339), T(2), S(1) A(5) A(3)
409 S N S(1215), G(10), N(10), R(1) S(163), N(16) S(250), N(91), R(1) S(5) N(3)
552 T S T(1166), A(70) T(179) T(390), N(2) T(5) T(3)
NP 16 G D G(1131), S(36) G(166), S(3) G(345), D(2), S(2) G(5) G(3)
33 V I V(793), I(373), A(1) V(169) V(348), I(1) V(5) V(3)
61 I L I(1164), M(3) I(168), L(1) I(346), L(2), M(1) I(5) I(3)
100 R V R(1162), K(5) R(168), I(1) R(344), K(5) R(5) R(3)
109 I V I(1161), V(4), T(2) I(169) I(344), S(2), T(2), V(1) I(5) I(3)
214 R K R(1164), K(3) R(169) R(322), K(26), L(1) R(5) R(3)
283 L P L(1166), P(1) L(168), P(1) L(347), P(2) L(5) L(3)
293 R K R(1161), K(6) R(169) R(349) R(5) R(3)
305 R K R(1167) R(169) R(346), S(2), K(1) R(5) R(3)
313 F Y F(1154), S(12), L(1) F(169) F(349) F(5) F(3)
357 Q K Q(1159), K(6), R(2) Q(168), K(1) Q(347), K(2) Q(5) Q(3)
372 E D E(1143), D(24) E(169) E(326), D(23) E(5) E(3)
422 R K R(1167) R(169) R(348), K(1) R(5) R(3)
442 T A T(1167) T(169) T(349) T(5) T(3)
455 D E D(1166), E(1) D(169) D(346), E(3) D(5) D(3)
M1 115 V I V(1846), G(1), I(1) V(199) V(835), I(11) V(5) V(3)
121 T A T(1847), A(1) T(198), S(1) T(804), A(41), N(1) T(5) T(3)
137 T A T(1830), A(18) T(149), A(50) T(841), A(5) T(5) T(3)
M2 11 T I T(1250), I(13), S(9) T(170) T(359), I(3), S(1) T(5) T(3)
20 S N S(1225), I(18), N(18), R(11) S(123), I(46), N(1) S(330), K(16), N(16), G(1) S(3), R(2) S(3)
57 Y H Y(1271), N(1) Y(170) Y(360), H(3) Y(5) Y(3)
86 V A V(1266), I(5), A(1) V(169), A(1) V(361), A(1), S(1) V(5) V(3)
93 N S N(1249), D(17), H(3),
Y(2), S(1)
N(170) N(362), S(1) N(5) N(3)
NS1 81 I M I(139), M(3), Gap(1778) I(19), Gap(213) I(745), V(27), A(5),
T(5), M(3)
I(6) I(3)
227 E R E(1840), G(55),






NS2 107 L F L(1403), Gap(1) L(195) L(608), P(2) L(6) L(3)
Residues in bold-and-underlined are human-like signatures; residues highlighted are neither human- nor avian-like signatures.
316 G.-W. Chen et al.to A/Shanghai/1/2013, with the top five as A/brambling/
Beijing/16/2012 (99.2%), A/chicken/Zhejiang/329/2011
(98.7%), A/chicken/Shanghai/C1/2012 (98.6%), A/duck/
Shanghai/C164/2009 (98.1%) and A/chicken/Jiangsu/Q3/2010 (98.0%). Co-incidentally, bramblings aremigratorybirds
that are widespread throughout the forests of northern Asia,
and the other four isolateswere from commonly seen poultry
in either Shanghai or nearby areas (Zhejiang and Jiangsu) as










E 805 128 245 0
K 242 49 4 3
V 0 0 51 0
G 0 0 1 0
Total 1047 177 301 3
K Percentage 23.11% 27.68% 1.33% 100.00%
Human infections by a new avian influenza A (H7N9) 317early as 2009. This demonstrates a high correlation between
the new H7N9 PB2 gene and the recently circulated avian
H9N2 viruses, based on both ecology (migratory birds) aswell
as geographic locations (greater Shanghai area). This obser-
vation reinforces the importance of continuously monitoring
the avian influenza virus genomes in these areas, both in
domestic poultry as well in migratory birds.
Although all the available cases of new H7N9 feature
PB2-627K, their potential for disrupting the species barrier
for human-to-human infection remains to be investigated.
Although its PB2 was derived from H9N2, we showed that
only four cases of PB2-627K were detected in all H9N2 PB2
sequences we have investigated. It is not clear how this
seemingly sporadic PB2-627K cases in H9N2 population had
triggered the recently reported fatal cases. In Tables 1 and
2 we observed the association of human-like residues be-
tween avian and human H5N1 viruses. Such inference is
statistically possible, thanks to the effort of global sur-
veillance of H5N1 viruses in the past decade. We have
already seen that the new H7N9 isolated from human is of
avian origin, and already contains several human like sig-
natures in its internal genes. It is likely that H7N9 will
evolve by taking a similar path to that of the H5N1 virus in
the past. Although the genetic outfits summarized in Table
1 for H9N2 viruses may provide certain clues of how the
internal genes for the new H7N9 may change, continuing to
monitor new H7N9 as well as related avian viruses (such as
H9N2) would be critical to better assess the potential for
the virus to cross the avian-human species barrier. If the
current H7N9 epidemic is not controlled soon, a future
possible pandemic may be eminent and then a good rapid
test assay24 and effective vaccine would be needed.
Acknowledgments
This work was sponsored by grants from the National Sci-
ence Council (NSC 100-2221-E-182-056-MY3; NSC101-2321-
B-002-005) and CMRPD1A0083.
References
1. Centers for Disease C, Prevention. Notes from the field: highly
pathogenic avian influenza A (H7N3) virus infection in two
poultry workersdJalisco, Mexico. Morb Mortal Wkly Rep July
2012;61:726e7.
2. Centers for Disease C, Prevention. Isolation of avian influenza
A(H5N1) viruses from humansdHong Kong. Morb Mortal Wkly
Rep MayeDecember 1997;46:1204e7.3. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM,
Kemink SA, Munster V, et al. Avian influenza A virus (H7N7)
associated with human conjunctivitis and a fatal case of acute
respiratory distress syndrome. Proc Natl Acad Sci U S A 2004;
101:1356e61.
4. Hwang SJ, Chang SC, Yu CJ, Chan YJ, Chen TJ, Hsieh SL, et al.
Immunogenicity and safety of an AS03(A)-adjuvanted H5N1
influenza vaccine in a Taiwanese population. J Formos Med
Assoc 2011;110:780e6.
5. Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S. Host
restriction of avian influenza viruses at the level of the ribo-
nucleoproteins. Annu Rev Microbiol 2008;62:403e24.
6. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human
infection with a novel avian-origin influenza A (H7N9) virus. N
Engl J Med 2013.
7. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E,
Munster VJ, et al. Airborne transmission of influenza A/H5N1
virus between ferrets. Science 2012;336:1534e41.
8. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al.
Experimental adaptation of an influenza H5 HA confers respi-
ratory droplet transmission to a reassortant H5 HA/H1N1 virus
in ferrets. Nature 2012;486:420e8.
9. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular
basis of the specific anti-influenza action of amantadine. EMBO
J 1985;4:3021e4.
10. Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has
ion channel activity. Cell 1992;69:517e28.
11. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for
high virulence of Hong Kong H5N1 influenza A viruses. Science
2001;293:1840e2.
12. Chen GW, Chang SC, Mok CK, Lo YL, Kung YN, Huang JH, et al.
Genomic signatures of human versus avian influenza A viruses.
Emerg Infect Dis 2006;12:1353e60.
13. Chen GW, Shih SR. Genomic signatures of influenza A pandemic
(H1N1) 2009 virus. Emerg Infect Dis 2009;15:1897e903.
14. Steel J, Lowen AC, Mubareka S, Palese P. Transmission of
influenza virus in a mammalian host is increased by PB2 amino
acids 627K or 627E/701N. PLOS Pathogens 2009;5:e1000252.
15. Liu Q, Qiao C, Marjuki H, Bawa B, Ma J, Guillossou S, et al.
Combination of PB2 271A and SR polymorphism at positions
590/591 is critical for viral replication and virulence of swine
influenza virus in cultured cells and in vivo. J Virol 2012;86:
1233e7.
16. Labadie K, Dos Santos Afonso E, Rameix-Welti MA, van der
Werf S, Naffakh N. Host-range determinants on the PB2 protein
of influenza A viruses control the interaction between the viral
polymerase and nucleoprotein in human cells. Virology 2007;
362:271e82.
17. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. PB2 amino
acid at position 627 affects replicative efficiency, but not cell
tropism, of Hong Kong H5N1 influenza A viruses in mice.
Virology 2004;320:258e66.
18. Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF,
Osterhaus AD, et al. The molecular basis of the pathogenicity
of the Dutch highly pathogenic human influenza A H7N7 vi-
ruses. J Infect Dis 2007;196:258e65.
19. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular
Biology Open Software Suite. Trends Genet 2000;16:276e7.
20. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A,
et al. Antigenic and genetic characteristics of swine-origin
2009 A(H1N1) influenza viruses circulating in humans. Science
2009;325:197e201.
21. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y,
et al. Genetic analysis of novel avian A(H7N9) influenza viruses
isolated from patients in China. Eur Commun Dis Bull February
to April 2013;18.
22. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD.
Human and avian influenza viruses target different cell types
318 G.-W. Chen et al.in cultures of human airway epithelium. Proc Natl Acad Sci U S
A 2004;101:4620e4.
23. Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA,
Naffakh N, Warnes C, et al. Neuraminidase stalk length and
additional glycosylation of the hemagglutinin influence thevirulence of influenza H5N1 viruses for mice. J Virol 2009;83:
4704e8.
24. Tai CF, Lu CY, Shao PL, Lee PI, Chang LY, Huang LM. Rapid-test
sensitivity for novel swine-origin pandemic influenza A. J For-
mos Med Assoc 2012;111:427e30.
